CQENS Technologies
Minneapolis, US · Delaware corporation
CQens designs devices and methods that heat plant-based and medicant-infused formulations to produce aerosols for inhalation, with a focus on harm reduction. The company operates in Nevada and California, holding a portfolio of 111 US and international patents.
Founders & leadership
WB
William BartkowskiExecutive
DM
Daniel MarkesExecutive
AC
Alexander ChongNamed on SEC filing
Reported raises · per SEC filings
Form D private placements$6.9M disclosed across 1 round · 2024
▶$6.9MraisedJan 2025 · 31 investors · Other TechnologyRule 506(b)
▶$6.9MraisedJan 2025 · 31 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- Alexander ChongExecutive Officer, Director
- William BartkowskiExecutive Officer
- Daniel MarkesExecutive Officer, Director
- Offering amount
- $20M
- Amount sold
- $6.9M
- Minimum investment
- $50K
- First sale
- May 2024
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
In the news
Frequently asked questions
- What does CQENS Technologies do?
- CQens designs devices and methods that heat plant-based and medicant-infused formulations to produce aerosols for inhalation, with a focus on harm reduction. The company operates in Nevada and California, holding a portfolio of 111 US and international patents.
- How much funding has CQENS Technologies raised?
- CQENS Technologies has disclosed $6.9M raised across 1 round.
- Where is CQENS Technologies headquartered?
- CQENS Technologies is headquartered in Minneapolis, US.